2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

      systematic-review

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Head and neck squamous cell carcinoma (HNSCC) exists within a microenvironment rich in immune cells. Macrophages are particularly abundant in and around tumor tissue, and have been implicated in the growth, malignancy, and persistence of HNSCC ( 1). However, current literature reports variable degrees of association between the density of tumor-associated macrophages (TAMs) and clinicopathologic markers of disease ( 2, 3). These inconsistent findings may be a result of differences in approach to TAM detection. Authors have measured total TAMs in tumor tissue, while others have stained tumor samples for individual subtypes of TAMs, which include pro-inflammatory (M1-like) and immunosuppressive (M2-like). Our aim is to more clearly define the prognostic significance of the phenotypes of tumor-associated macrophages in HNSCC.

          Methods: We conducted a meta-analysis of the existing publications investigating the relationship between TAMs (total and M2-like subtype) and T stage, nodal involvement, vascular invasion, lymphatic invasion, and tumor differentiation ( Figure 1). A total of 12 studies were included. Forest plots and risk ratios were generated to report overall effect.

          Results: Higher density of both total and M2-like subtype of TAMs in the tumor microenvironment is associated with advanced T stage, increased rates of nodal positivity, presence of vascular invasion, and presence of lymphatic invasion ( p < 0.0001; Figures 2–9). There is no significant association between TAM density, either total or M2-like subtype, and tumor differentiation ( Figures 10, 11).

          Conclusions: Increased density of TAMs, including those of the M2-like phenotype, correlate with poor clinicopathologic markers in HNSCC. Our findings warrant additional investigation into the subpopulations of TAMs, the mechanisms behind their recruitment and differentiation, and the associated influence of each phenotype on tumor growth and invasion. A greater understanding of TAM dynamics in HNSCC is critical for directing further research and employing TAM-targeted adjunct therapies.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms

          The alternatively activated or M2 macrophages are immune cells with high phenotypic heterogeneity and are governing functions at the interface of immunity, tissue homeostasis, metabolism, and endocrine signaling. Today the M2 macrophages are identified based on the expression pattern of a set of M2 markers. These markers are transmembrane glycoproteins, scavenger receptors, enzymes, growth factors, hormones, cytokines, and cytokine receptors with diverse and often yet unexplored functions. This review discusses whether these M2 markers can be reliably used to identify M2 macrophages and define their functional subdivisions. Also, it provides an update on the novel signals of the tissue environment and the neuroendocrine system which shape the M2 activation. The possible evolutionary roots of the M2 macrophage functions are also discussed.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Tumor-associated macrophages: from basic research to clinical application

            The fact that various immune cells, including macrophages, can be found in tumor tissues has long been known. With the introduction of concept that macrophages differentiate into a classically or alternatively activated phenotype, the role of tumor-associated macrophages (TAMs) is now beginning to be elucidated. TAMs act as “protumoral macrophages,” contributing to disease progression. TAMs can promote initiation and metastasis of tumor cells, inhibit antitumor immune responses mediated by T cells, and stimulate tumor angiogenesis and subsequently tumor progression. As the relationship between TAMs and malignant tumors becomes clearer, TAMs are beginning to be seen as potential biomarkers for diagnosis and prognosis of cancers, as well as therapeutic targets in these cases. In this review, we will discuss the origin, polarization, and role of TAMs in human malignant tumors, as well as how TAMs can be used as diagnostic and prognostic biomarkers and therapeutic targets of cancer in clinics.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Macrophages in Tumor Microenvironments and the Progression of Tumors

              Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF- α , iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF- β , and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                23 July 2019
                2019
                : 9
                : 656
                Affiliations
                [1] 1Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University , Philadelphia, PA, United States
                [2] 2Sidney Kimmel Medical College, Thomas Jefferson University , Philadelphia, PA, United States
                [3] 3Department of Medical Oncology, Thomas Jefferson University , Philadelphia, PA, United States
                [4] 4Department of Neurological Surgery, Thomas Jefferson University , Philadelphia, PA, United States
                [5] 5Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University , Philadelphia, PA, United States
                [6] 6Department of Dermatology, Thomas Jefferson University , Philadelphia, PA, United States
                Author notes

                Edited by: Christian Simon, Lausanne University Hospital (CHUV), Switzerland

                Reviewed by: Hong-Yan Qin, Fourth Military Medical University, China; Yoshihiro Komohara, Kumamoto University, Japan

                *Correspondence: Ayan Tyagi Kumar Ayan.kumar@ 123456jefferson.edu

                This article was submitted to Head and Neck Cancer, a section of the journal Frontiers in Oncology

                Article
                10.3389/fonc.2019.00656
                6663973
                30761267
                235c1677-c045-41ad-a56c-4c67e8a63c13
                Copyright © 2019 Kumar, Knops, Swendseid, Martinez-Outschoom, Harshyne, Philp, Rodeck, Luginbuhl, Cognetti, Johnson and Curry.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 11 January 2019
                : 04 July 2019
                Page count
                Figures: 11, Tables: 1, Equations: 0, References: 69, Pages: 10, Words: 6455
                Categories
                Oncology
                Systematic Review

                Oncology & Radiotherapy
                tumor microenviroment,tumor associated macrophage (tam),head and neck (h&n) cancer,cd68,cd163,m1 macrolphage,m2 macrophage

                Comments

                Comment on this article